drugset / Trial / NCT02068352
A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the effectiveness and safety of 2 concentrations of OPA-15406 compared to vehicle in participants with atopic dermatitis (AD).
Timeline
- Start
- 2014-06-20
- Primary completion
- 2015-01-28
- Completion
- 2015-02-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Difamilast | Small molecule | 0.3 % | Topical |
| Subject | Difamilast | Small molecule | 1 % | Topical |